Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ian McCafferty is active.

Publication


Featured researches published by Ian McCafferty.


Clinical Radiology | 2013

Prostate MRI: Who, when, and how? Report from a UK consensus meeting

Alex Kirkham; Philip Haslam; J.Y. Keanie; Ian McCafferty; Anwar R. Padhani; Shonit Punwani; J. Richenberg; G. Rottenberg; Aslam Sohaib; P. Thompson; Lindsay W. Turnbull; L. Kurban; Anju Sahdev; R. Clements; B.M. Carey; Clare Allen

The current pathway for men suspected of having prostate cancer [transrectal biopsy, followed in some cases by magnetic resonance imaging (MRI) for staging] results in over-diagnosis of insignificant tumours, and systematically misses disease in the anterior prostate. Multiparametric MRI has the potential to change this pathway, and if performed before biopsy, might enable the exclusion of significant disease in some men without biopsy, targeted biopsy in others, and improvements in the performance of active surveillance. For the potential benefits to be realized, the setting of standards is vital. This article summarizes the outcome of a meeting of UK radiologists, at which a consensus was achieved on (1) the indications for MRI, (2) the conduct of the scan, (3) a method and template for reporting, and (4) minimum standards for radiologists.


Journal of Vascular and Interventional Radiology | 2011

Long-term results of stent-graft placement to treat central venous stenosis and occlusion in hemodialysis patients with arteriovenous fistulas.

Robert G. Jones; Andrew P. Willis; Catherine Jones; Ian McCafferty; Peter Riley

PURPOSE To determine the effectiveness of stent-grafts for the treatment of central venous disease in hemodialysis patients with functioning arteriovenous (AV) fistulas. MATERIALS AND METHODS Between October 2004 and March 2010, 42 VIABAHN stent-grafts were deployed in central veins of 30 patients (16 men, 14 women; mean age 60 y) with functioning AV fistulas and central venous disease that did not respond to percutaneous transluminal angioplasty (PTA). Eighteen patients had central vein stenosis and 12 had occlusion. Previous PTA and/or bare metal stent placement had been performed in 23 patients (77%). Surveillance was carried out at 3, 6, 9, 12, 18, and 24 months with diagnostic fistulography. The mean follow-up was 705 days (range, 66-1,645 d). Statistical analysis included Kaplan-Meier and log-rank studies. RESULTS Technical success rate was 100%. Primary patency rates were 97%, 81%, 67%, and 45% at 3, 6, 12, and 24 months, respectively. Primary assisted patency rates were 100%, 100%, 80%, and 75% at 3, 6, 12, and 24 months, respectively. Patients without previous procedures had significantly shorter times to repeat intervention (P = .018) than those who had undergone PTA or bare metal stent placement previously. Patients with occlusive lesions had a significantly shorter primary patency interval (P = .05) than patients with stenoses. Occluded veins were more likely to require further stent-grafts (P = .02). Twelve patients required further stent-grafts to maintain patency. There was one minor complication. CONCLUSIONS Stent-graft placement to treat central venous disease in hemodialysis patients with autogenous AV fistulas is safe and effective if PTA fails to maintain luminal patency.


Clinical Radiology | 2011

Imaging and management of vascular malformations

Ian McCafferty; R.G. Jones

Vascular malformations are a diffuse collection of abnormalities that are usually present at birth but may present any time during childhood or as an adult. Historically terminology has been complicated and used interchangeably causing confusion to patients and clinicians alike; however, a structured internationally agreed classification system exists. It is not uncommon for patients with vascular malformations to be referred to various specialties without obtaining a correct diagnosis and appropriate treatment. Vascular malformations can occur anywhere within the body and all patients will require imaging at some stage; therefore, it is important for all radiologists to be aware of the correct terminology and imaging characteristics. This review discusses classification and illustrates salient imaging findings and the modern approach to treatment of vascular malformations.


Clinical Radiology | 2013

Inferior vena cava filters: What radiologists need to know

J.J. Harvey; J. Hopkins; Ian McCafferty; Robert G. Jones

Inferior vena cava (IVC) filters are a controversial mechanical adjunct in the prevention of pulmonary embolism, the most serious result of venous thromboembolism. Despite modern IVC filters being in clinical use for more than 45 years, there is still uncertainty amongst many radiologists about the indications for IVC filter placement and their removal, particularly the more recent prophylactic use in patients without confirmed deep vein thrombosis (DVT) or pulmonary embolism (PE). Recently published guidelines on filter use from the National Institute of Health and Clinical Excellence (NICE) and other professional bodies are discussed. The vast majority of IVC filters in the UK are inserted by interventional radiologists, so radiologists may be the first point of contact for information requested by other clinicians. The increasing use of filters means that radiologists will encounter filters increasingly often during abdominal cross-sectional imaging. Awareness of common filter-related complications, such as tilting, thrombosis, and caval perforation, is useful to reassure or alert other clinicians. The potential role of filters in upper extremity DVT and requirement for concomitant anticoagulation is discussed.


CardioVascular and Interventional Radiology | 2005

Radiological Management of Superior Vena Caval Stent Migration and Infection

Sadeesh Srinathan; Ian McCafferty; Ian Wilson

We report a case of venous obstruction secondary to Hodgkin’s lymphoma. Multiple Wallstents were inserted into the superior vena cava to relieve obstructive symptoms secondary to tumor. This procedure was complicated by stent migration into the right ventricle and a presumed stent infection. We describe the percutaneous management of these complications and discuss the issues surrounding the use of stents in this setting. We conclude that these complications can be managed percutaneously. However, the technical details of stent placement are essential in minimizing complications of this type.


CardioVascular and Interventional Radiology | 2015

Management of Low-Flow Vascular Malformations: Clinical Presentation, Classification, Patient Selection, Imaging and Treatment

Ian McCafferty

This review article aims to give an overview of the current state of imaging, patient selection, agents and techniques used in the management of low-flow vascular malformations. The review includes the current classifications for low-flow vascular malformations including the 2014 updates. Clinical presentation and assessment is covered with a detailed section on the common sclerosant agents used to treat low-flow vascular malformations, including dosing and common complications. Imaging is described with a guide to a simple stratification of the use of imaging for diagnosis and interventional techniques.


Clinical Radiology | 1998

Multiplanar reformatting and three-dimensional reconstruction : for pre-operative assessment of the thoracic aorta by computed tomography

K.A. Bradshaw; Domenico Pagano; Robert S. Bonser; Ian McCafferty; Peter Guest

INTRODUCTION Conventional CT demonstrates pathology of the thoracic aorta. This study aimed to evaluate the additional contributions to surgical planning of multiplanar reformatting, maximum intensity projections and three-dimensional (3-D) reconstruction. DESIGN Retrospective. SUBJECT AND METHODOLOGY: Fifty-three patients with newly diagnosed pathology of the thoracic aorta were scanned over a 15-month period; 25 scans were spiral acquisitions. Scans were acquired during and following rapid injection of 100 ml of intravenous iopromide. The reconstructed data was displayed as axial images, oblique or other multiplanar reformats and shaded surface display 3-D reconstructions. Two radiologists and two surgeons reviewed the images. The axial images were assessed initially, subsequently the reformats and 3-D reconstructed views were examined looking particularly for additional information that might add to the surgical management. RESULTS Pathologies encountered were aortic dissection (21 patients, including two with Marfans syndrome), saccular aneurysms (eight), fusiform aneurysms (16), aortic root and ascending aortic dilatation (seven) and coarctation (one). The relationship of aneurysms and dissections to major vessels are better shown with 3-D reconstruction or oblique reformats. Morphology of saccular aneurysms, particularly the neck, is well shown with 3-D reconstruction. Coarctation was best demonstrated by oblique reformats. There was little additional information from 3-D reconstruction or reformats in assessment of type A dissection. Improved spatial orientation by visualization in varying projections was helpful for surgical planning in certain cases of type B dissection, fusiform aneurysms and aortic root and ascending aortic root dilatation. Spiral acquisitions have the advantage of speed and hence a greater anatomical coverage for a single breath-hold. CONCLUSION Oblique reformats and 3-D reconstruction, although using identical data as the axial images, in specific cases were felt to aid surgical assessment of aneurysms and dissections, thus assisting pre-operative planning.


British Journal of Oral & Maxillofacial Surgery | 2009

The use of foam sclerotherapy for the treatment of head and neck vascular malformations

Khaleeq-Ur Rehman; Ganeshwaran Sittampalam; Ian McCafferty; Andrew Monaghan

ascular malformations can be treated in different ways epending on the type of lesion and its presenting symptoms. ne of the simplest conservative ways is by sclerotherapy, hich is done by an interventional radiologist who injects sclerosant into the lesion under ultrasound guidance. This auses an intense inflammatory reaction within the lesion, nd fibrosis during healing causes the lesion to shrink. The sclerosant used is Fibro-vein (STD Pharmaceutical, ereford, UK), which contains sodium tetradecyl sulphate STD), a commonly used agent in the treatment of lower


Journal of Cardiac Surgery | 2007

Emergency endovascular stent graft repair of aorto-bronchial fistulas postcoarctation repair.

Anand Sachithanandan; Ian McCafferty; Peter Riley; Robert S. Bonser; Stephen J. Rooney

Abstract  Cardiovascular complications following coarctation repair include aorto bronchial fistulas (ABF) which if untreated are invariably fatal. Reoperative surgery is associated with considerable mortality and morbidity. Endovascular stent aortoplasty provides a relatively new and viable alternative. Two cases of ABF post coarctation repair that presented with life threatening haemoptysis are discussed. Endovascular repair appears safe and feasible in an emergency and may become the preferred treatment modality in such cases.


BMJ Open | 2017

Cross-sectional study of the provision of interventional oncology services in the UK

Jim Zhong; Peter Atiiga; Des J Alcorn; David Kay; Rowland Illing; David J. Breen; Nicholas Railton; Ian McCafferty; Philip Haslam; Tze Min Wah

Objective To map out the current provision of interventional oncology (IO) services in the UK. Design Cross-sectional multicentre study. Setting All National Health Service (NHS) trusts in England and Scottish, Welsh and Northern Ireland health boards. Participants Interventional radiology (IR) departments in all NHS trusts/health boards in the UK. Results A total of 179 NHS trusts/health boards were contacted. We received a 100% response rate. Only 19 (11%) institutions had an IO lead. 144 trusts (80%) provided IO services or had a formal pathway of referral in place for patients to a recipient trust. 21 trusts (12%) had plans to provide an IO service or formal referral pathway in the next 12 months only. 14 trusts (8%) did not have a pathway of referral and no plans to implement one. 70 trusts (39%) offered supportive and disease-modifying procedures. One trust had a formal referral pathway for supportive procedures. 73 trusts (41%) provided only supportive procedures (diagnostic or therapeutic). Of these, 43 (59%) had a referral pathway for disease-modifying IO procedures, either from a regional cancer network or through IR networks and 30 trusts (41%) did not have a referral pathway for disease-modifying procedures. Conclusion The provision of IO services in the UK is promising; however, collaborative networks are necessary to ensure disease-modifying IO procedures are made accessible to all patients and to facilitate larger registry data for research with commissioning of new services.

Collaboration


Dive into the Ian McCafferty's collaboration.

Top Co-Authors

Avatar

Peter Riley

Queen Elizabeth Hospital Birmingham

View shared research outputs
Top Co-Authors

Avatar

Jorge Mascaro

Queen Elizabeth Hospital Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald J. Adam

Heart of England NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Martin Claridge

Heart of England NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Mauro Iafrancesco

Heart of England NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Robert G. Jones

Queen Elizabeth Hospital Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Monaghan

Queen Elizabeth Hospital Birmingham

View shared research outputs
Top Co-Authors

Avatar

G.A.E. Burke

Queen Elizabeth Hospital Birmingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge